News last week (05.18—05.24)

新冠疫情 COVID-19

●《自然》发表最新研究称，SARS治愈者抗体可抑制新冠病毒

SARS-CoV-2 can be inhibited by antibodies from SARS patients, according to a new study published in Nature

国际学术期刊《自然》最新发表的一篇免疫学研究成果论文称，从严重急性呼吸系统综合征（SARS）治愈者体内分离出的S309抗体，可以有效阻断新型冠状病毒（SARS-CoV-2）的传染性。最新发表成果论文的共同通讯作者为美国华盛顿大学戴维·韦斯勒（David Veesler）和瑞士Vir生物技术公司戴维德·科尔蒂（Davide Corti）。（中国新闻网）

The coronavirus (SARS-CoV-2) can be effectively prevented from infecting patients with severe acute respiratory syndrome (SARS) by S309 antibodies isolated from patients with the disease, according to a new immunological study published in the international journal Nature. The corresponding authors of the paper are David Veesler of the University of Washington and Davide Corti of the Swiss Biotechnology Company Vir. (chinanews.com)

●新冠疫苗：8个进入临床试验，瞄准9月紧急使用

COVID-19 vaccine: 8 reached clinical trials phase, aiming for emergency use in September

截至5月11日，世界卫生组织的官网上已经备案了110个正在研发的新冠肺炎疫苗，其中已经进入临床试验的共有8个。这8个疫苗中，4个来自中国研发团队，3个来自美国，一个来自英国，采用的技术平台分别是非复制性病毒载体、RNA、灭活疫苗和DNA。中国疾控中心主任高福在4月23日接受中国国际电视台采访时表示，中国处于新冠疫苗研发的前沿，在9月份可能有新冠疫苗投入紧急使用。（澎湃新闻）

As of May 11,the WHO website has documented 110 COVID-19 vaccines in development, of which eight have reached clinical trials phase.Four of the eight vaccines were developed by Chinese teams,three from the United States and one from the United Kingdom, using non-replicating viral vectors, RNA, inactivated virus and DNA as carriers. Gaofu, director of the China Center for Disease Control and Prevention, said in an interview that China is at the forefront of COVID-19 vaccine research and development, and that a COVID-19 vaccine may be put into emergency use in September. (thepaper.cn)

●武汉团队找到3个新冠病毒标志物，预测患者个体死亡率，准确率超九成

The Wuhan team found three SARS-CoV-2 markers, which could predict the individual mortality of patients with an accuracy of more than 90%

华中科技大学同济医学院附属同济医院等机构在学术期刊《自然-机器智能》发文表示，利用3个生物标志物，机器学习算法可以至少提前10天预测新冠肺炎患者个体的死亡率，准确率超过90%。这3个生物标志物分别是乳酸脱氢酶、淋巴细胞和超敏C反应蛋白水平。（澎湃新闻）

Using three biomarkers, the machine learning algorithm can predict the individual mortality rate of COVID-19 patients at least 10 days in advance, with an accuracy of more than 90 percent, according to a paper published in the journal Nature Machine Intelligence by Tongji Hospital. The three biomarkers were lactate dehydrogenase, lymphocyte and the level of hs-CRP. (thepaper.cn)

●荷兰政府：水貂可能将新冠病毒传给人

Dutch government: a mink may transmit COVID-19 to a person

当地时间5月19日，荷兰政府报告了一起疑似新冠病毒通过动物传人的案例。政府在官网发布声明称，有证据表明，有人从水貂身上感染了新冠病毒，因此正对境内所有水貂养殖场进行强制性清查。荷兰农业部认为水貂同样可以感染新冠病毒，包括无症状感染。（观察者）

On May 19, local time, the Dutch government reported a suspected COVID-19 animal transmission case. In a statement on its website, the government said it was conducting a mandatory inventory of all mink farms in the country because of evidence that someone had contracted COVID-19 from a mink. The coronavirus can also infect minks, including asymptomatic infections, according to the Dutch Ministry of Agriculture. (guancha.cn)

科学技术 Science & Technology

●《细胞》重磅论文：脑机接口逆转瘫痪

Cell: brain-computer interface reverses paralysis

美国俄亥俄州哥伦布市巴特尔纪念研究所的研究员，经过多年的研究和试验，

首次在脑机接口上成功实时分离了人体神经的运动和触觉信号，并将这些信号同时用于神经反馈和义肢操控，在一名四肢瘫痪者的右手上实现了运动和触觉的同时恢复。

这项重磅研究，于近日正式刊登在世界顶级权威学术期刊《细胞》上。（品玩）

After years of research and experimentation, for the first time, researchers at the Battle Memorial Research Institute in Columbus, Ohio successfully separated the motor and tactile signals of human nerves in real  time on the brain-computer interface, and used these signals for both neuro feedback and manipulation of a prosthetic limb. And the simultaneous recovery of motor and tactile signals was achieved in the right hand of a quadriplegic. The blockbuster study was published recently in the world's leading academic journal Cell. (PingWest)

●香港科技大学研发革命性人造视网膜，论文登上《自然》

HKUST develops revolutionary artifcial retina, and the paper were published in Nature

在最新出版的《自然》杂志上，香港科技大学顾磊磊（Leilei Gu）、范智勇等人在论文《A biomimetic eye with a hemispherical perovskite nanowire array retina》中提出了一种创新的凹半球“视网膜”，由模仿人类视网膜中感光细胞的纳米级光电传感器阵列组成。研究者使用基于这套设备的电化学人造眼，在多项测试中与人眼进行对比，发现“人造眼”已具有获取图像图案的基本能力。（机器之心）

In their paper "A biomimetic eye with A hemisphere pherical perovskite nanowire array retina", published in the latest issue of the journal Nature, Gu Leilei and Fan Zhiyong of HKUST propose an innovative hemispherical "retina", which consists of a nanoscale photoelectric sensor array that imitate the photoreceptor cells in the human retina. Using an electrochemical artificial eye based on the device, the researchers compared it to human eyes in a number of tests and found that the "artificial eye" already had the basic ability to capture patterns in images. (jiqizhixin.com)

●香港浸会大学发明纳米基质快速培养微型脑样结构，有助帕金森治疗

HKBU has developed a nanometer matrix to rapidly grow micro-brain-like structures for Parkinson's disease

香港浸会大学5月21日宣布，该校研究团队发明了一款新的纳米基质，能快速培养出微型脑样结构，取代脑部受损部分，这项发明有助改善帕金森症病情，为治疗此疾病带来新启示。（新华社）

A team of researchers at HKBU has developed a new nano-matrix material that can rapidly grow micro-brain-like structures to replace damaged parts of the brain. It could lead to improved treatments for Parkinson's disease, the university said on Tuesday. (xinhua)

●苹果计划发售AR眼镜 Apple Glass

Apple plans to release Apple Glass, its AR eyewear

苹果公司计划推出一款全新的AR眼镜产品，并将其命名为“Apple Glass”。产品将于今年第四季度至明年第一季度之间，在发布会上作为 One More Thing 发布，在 2021 Q4 至 2022 Q1 之间正式发售，售价在 499 美元以上。（锋科技）

Apple plans to launch a new AR eyewear product called Apple Glass. The product will be launched as One More Thing between the fourth quarter of this year and the first quarter of next year, and will be officially released between 2021 Q4 and 2022 Q1 at a price of more than 499 US dollars. (tech.feng.com)